VIVUS INC
DelistedCIK 881524fmd_06RP8YCAWCD5HTP5FFKAW1GY3MManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2020, 42 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 2 | 81 | 114 | 95 | 124 | 65 | 65 | 70 |
| Net interest income | – | 0 | 0 | (20) | (33) | – | – | – | – | – |
| Cost of revenue | – | – | 0 | 5 | 33 | 34 | 10 | 17 | 15 | 16 |
| Gross profit | – | – | 2 | 76 | 81 | 61 | 114 | 49 | 50 | 54 |
| Research and development | 40 | 25 | 32 | 30 | 14 | 10 | 6 | 5 | 7 | 10 |
| Selling, general and administrative | – | 22 | 110 | 158 | 112 | 79 | 52 | 40 | 38 | 40 |
| Total operating expenses | 66 | 47 | 142 | 236 | 165 | 156 | 69 | 63 | 69 | – |
| Operating income | (66) | (47) | (140) | (155) | (51) | (60) | 56 | 3 | (3) | (11) |
| Interest expense | 4 | 0 | – | – | – | – | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (10) | 0 | 0 | (20) | (33) | (33) | (32) | (33) | (33) | (21) |
| Income before taxes | (75) | (47) | (140) | (175) | (83) | (93) | 23 | (31) | (37) | (31) |
| Income tax expense | 0 | 0 | 0 | 0 | (1) | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (75) | (47) | (140) | (175) | (83) | (93) | 23 | (31) | (37) | (32) |
| Net income | (66) | (46) | (140) | (174) | (83) | (93) | 23 | (31) | (37) | (32) |